Weight loss jabs: New guidance issued following pancreatitis surge
UK regulator urges vigilance over pancreatitis after weight‑loss jab surge.
On 30 January 2026, the UK medicines regulator MHRA issued updated guidance for popular weight‑loss and diabetes injections following a surge in acute pancreatitis reports. The advisory, written by Solen Le Net, warns clinicians and patients to watch for abdominal pain, nausea and vomiting after receiving GLP‑1 analogs such as semaglutide (Wegovy, Ozempic). The guidance follows a rise in pancreatitis cases linked to these drugs over the past year, prompting the regulator to urge heightened vigilance and early reporting. MHRA’s statement, posted on the GB News website at 10:28 UTC, highlights the need for prompt assessment and potential discontinuation of therapy when symptoms arise.
Tags
Related Posts
RCB vs CSK: Tim David goes ballistic, equals AB de Villiers record to ...
Batting in the lower middle order at the M Chinnaswamy Stadium, David struck eight sixes during his innings. That effort is now the joint second highest number of sixes hit by an RCB batter from No. 5 or lower in an IPL match
US: Gunfire reported near White House, Secret Service launches probe
US: Gunfire reported near White House, Secret Service launches probe
Amid job cuts, Canadian billionaire Kevin O’Leary points out a good thing about AI layoffs
Kevin O Leary, the Canadian billionaire, asserts that artificial intelligence is elevating human creativity, making artists and storytellers more valuable than ever. He highlights how compelling social media content, especially short form videos, now commands significant salaries due to measurable customer acquisition. O Leary believes AI is a powerful productivity tool, fostering new industries and opportunities across all economic sectors